Showing results (1-10 of 18) with videos related to

Sort By:
Pageof 2
Pharmaceutical Research|April 23, 2005
Treatment of hyperbilirubinemia in Eisai hyperbilirubinemic rat by transfecting human MRP2/ABCC2 geneMasakazu Hirouchi, Hiroshi Suzuki, Yuichi Sugiyama
The Journal of Pharmacology and Experimental Therapeutics|August 23, 2008
Increasing systemic exposure of methotrexate by active efflux mediated by multidrug resistance-associated protein 3 (mrp3/abcc3)Yoshiaki Kitamura, Masakazu Hirouchi, Hiroyuki Kusuhara, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals|May 4, 2013
Integrated approach of in vivo and in vitro evaluation of the involvement of hepatic uptake organic anion transporters in the drug disposition in rats using rifampicin as an inhibitorTomoki Imaoka, Tsuyoshi Mikkaichi, Koji Abe, et al.
International Journal of Molecular Sciences|January 8, 2025
Plasma microRNAs Associate Positive, Negative, and Cognitive Symptoms with Inflammation in SchizophreniaTakuya Miyano, Masakazu Hirouchi, Naoki Yoshimura, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals|April 21, 2006
Involvement of transporters in the hepatic uptake and biliary excretion of valsartan, a selective antagonist of the angiotensin II AT1-receptor, in humansWakaba Yamashiro, Kazuya Maeda, Masakazu Hirouchi, et al.
Bioorganic & Medicinal Chemistry Letters|March 27, 2013
Arylpiperazines as fatty acid transport protein 1 (FATP1) inhibitors with improved potency and pharmacokinetic propertiesTetsuyoshi Matsufuji, Mika Ikeda, Asuka Naito, et al.
Pharmaceutical Research|June 8, 2004
Characterization of the cellular localization, expression level, and function of SNP variants of MRP2/ABCC2Masakazu Hirouchi, Hiroshi Suzuki, Masaya Itoda, et al.
Bioorganic & Medicinal Chemistry Letters|July 4, 2012
Discovery and optimization of novel fatty acid transport protein 1 (FATP1) inhibitorsTetsuyoshi Matsufuji, Mika Ikeda, Asuka Naito, et al.
Bioorganic & Medicinal Chemistry Letters|January 20, 2022
Discovery of DS-3801b, a non-macrolide GPR38 agonist with N-methylanilide structureNarihiro Toda, Takeshi Shida, Rieko Takano, et al.
Pageof 2